Patent №
US 8,099,298
Granted
2012-01-17
Filed 2008
Owner
GENELEX CORPORATION
Lab
—
AI components
3
nlp · kr · planning
Assignment
Recorded
Dataset
AIPD
2023_r1 edition
Application
12031327
A computerized tool and method for delivery of pharmacogenetic and pharmacological information, comprising a core system having algorithms and databases for storing, collating, accessing, cross-referencing, and interpreting genetic and pharmacologic data, with a graphical user interface for a client network of providers of laboratory genetic testing services to access the core services under contract. The system includes “paypoints” in support of improved business models. Included are mechanisms for ‘pass through’ third party and insurance reimbursement for interpretive reports, insurance reimbursement for on-line access to pharmacogenetic information at the point of care, tools for market segmentation, and a conversion tool for capturing new subscribers. Also disclosed are tools and predictive algorithms for preventing drug-drug and drug-gene adverse drug reactions.
AI classification
Ownership
GENELEX CORPORATION
assignment · 207160426
Assignors
COLEMAN, HOWARD C, OESTERHELD, JESSICA, PATTERSON, ROBERT D
On an employer assignment, the assignors are typically the inventors.